Proteomics

Dataset Information

0

CD8 T cell phosphoproteome LC-MSMS


ABSTRACT: Label-free phosphoproteome measurements of donor-derived CD8 T cells with and without cell cycle blockers.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Primary Cell

SUBMITTER: Rayman Tjokrodirijo  

LAB HEAD: Peter van Veelen

PROVIDER: PXD055517 | Pride | 2026-03-09

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
E20202000308.raw Raw
E20202000309.raw Raw
E20202000310.raw Raw
E20202000311.raw Raw
E20202000312.raw Raw
Items per page:
1 - 5 of 11
altmetric image

Publications

Cell cycle arrest enhances CD8<sup>+</sup> T cell effector function by potentiating glucose metabolism and IL-2 signaling.

van Haften Floortje J FJ   van der Sluis Tetje C TC   Hepp Hanna S HS   Mülling Nils N   Nadafi Reza R   Sampadi Bharath B   van Duikeren Suzanne S   Mostert J Shirin JS   van der Sterre Rosemarijn R   van Veelen Peter A PA   Heieis Graham A GA   Veerkamp Dominique M B DMB   Wesselink Thomas H TH   Vleeshouwers Ward W   Beijnes Macha M   Pardieck Iris N IN   van Horssen Eralin L F ELF   de Groot Anne F AF   van der Ploeg Manon M   Kroep Judith R JR   de Miranda Noel F C C NFCC   van der Zanden Sabina Y SY   Neefjes Jacques J   Mei Hailiang H   Vertegaal Alfred C O ACO   Everts Bart B   van der Burg Sjoerd H SH   Arens Ramon R  

Nature immunology 20260119


Cell cycle-inhibiting chemotherapeutics are widely used in cancer treatment. Although the primary aim is to block tumor cell proliferation, their clinical efficacy also involves specific effector CD8<sup>+</sup> T cells that undergo synchronized proliferation and differentiation. How CD8<sup>+</sup> T cells are programmed when these processes are uncoupled, as occurs during cell cycle inhibition, is unclear. Here, we show that activated CD8<sup>+</sup> T cells arrested in their cell cycle can st  ...[more]

Similar Datasets

2023-01-18 | PXD013620 | Pride
2025-11-24 | PXD064514 | Pride
2022-08-12 | PXD022765 | Pride
2026-03-19 | PXD068553 | Pride
2023-02-13 | PXD039532 | Pride
2025-04-25 | PXD063291 | Pride
2025-07-21 | PXD062619 | Pride
2025-07-21 | PXD062616 | Pride
2021-10-08 | PXD024522 | Pride
2021-07-14 | PXD023441 | Pride